BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 8394847)

  • 21. The effect of ACTH4-9 analog (Org2766) on some cerebrospinal fluid parameters in patients with Alzheimer's disease.
    Jolkkonen JT; Soininen HS; Riekkinen PJ
    Life Sci; 1985 Aug; 37(7):585-90. PubMed ID: 2991689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of synthetic neuropeptides in psycho-organic brain syndrome. Results with ACTH4-10 and ACTH4-9-analog (author's transl)].
    Schneider E; Jacobi P; van Riezen H; Voerman JW; Fischer PA
    Pharmacopsychiatria; 1981 Sep; 14(5):155-9. PubMed ID: 6270708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does an ACTH derivative (Org 2766) prevent deterioration of EEG in Alzheimer's disease?
    Partanen JV; Soininen H; Riekkinen PJ
    Electroencephalogr Clin Neurophysiol; 1986 Jun; 63(6):547-51. PubMed ID: 2422004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First clinical impressions with an ACTH analog (HOE 427) in the treatment of Alzheimer's disease.
    Siegfried KR
    Ann N Y Acad Sci; 1991; 640():280-3. PubMed ID: 1663715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurochemical effects of the synthetic ACTH4-9-analog Hoe 427 (Ebiratide) in rat brain.
    Wiemer G; Gerhards HJ; Hock FJ; Usinger P; Von Rechenberg W; Geiger R
    Peptides; 1988; 9(5):1081-7. PubMed ID: 2854245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ACTH 4-9 analogue (Org 2766) in depressed elderly patients. I. Effect on depressed mood.
    Frederiksen SO; d'Elia G; Bengtsson BO
    Acta Psychiatr Scand; 1985 Oct; 72(4):341-8. PubMed ID: 3000138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inositol treatment of Alzheimer's disease: a double blind, cross-over placebo controlled trial.
    Barak Y; Levine J; Glasman A; Elizur A; Belmaker RH
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 May; 20(4):729-35. PubMed ID: 8843494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The neurotrophic effects of ebiratide, an analog of ACTH4-9, on cultured septal cells and aged rats.
    Matsumoto T; Tsuda S; Nakamura S
    J Neural Transm Gen Sect; 1995; 100(1):1-15. PubMed ID: 8748659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain transfer of a new neuromodulating ACTH analog, ebiratide, in rats.
    Shimura T; Tabata S; Hayashi S
    Peptides; 1991; 12(3):509-12. PubMed ID: 1681522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Recent drug therapy of senile dementia].
    Ohtomo E
    No To Shinkei; 1987 Jan; 39(1):49-58. PubMed ID: 3030382
    [No Abstract]   [Full Text] [Related]  

  • 31. Neuropeptides: ACTH-peptides in dementia.
    Kragh-Sørensen P; Olsen RB; Lund S; Van Riezen H; Steffensen K
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):479-92. PubMed ID: 3025927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early visual information processing in depressive patients treated with ORG 2766 (an ACTH 4-9 analogue).
    d'Elia G; Frederiksen SO; Bengtsson BO
    Neuropsychobiology; 1985; 13(1-2):63-8. PubMed ID: 2993946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of adrenocorticotropic hormone (ACTH4-10) on information network of the cardiovascular systems].
    Dmitrieva NV; Lonskaia LF; Bakaneva VF
    Vestn Ross Akad Med Nauk; 2010; (3):21-4. PubMed ID: 20420211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An analog of MSH/ACTH 4-9 enhances interpersonal and environmental awareness in mentally retarded adults.
    Sandman CA; Walker BB; Lawton CA
    Peptides; 1980; 1(1):109-14. PubMed ID: 7243605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ACTH4-10: cognitive and behavioral effects in hyperactive, learning-disabled children.
    Rapoport JL; Quinn PO; Copeland AP; Burg C
    Neuropsychobiology; 1976; 2(5-6):291-6. PubMed ID: 197444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous nicotine in a patient with Alzheimer's disease.
    Newhouse PA; Sunderland T; Thompson K; Tariot PN; Weingartner H; Mueller ER; Cohen RM; Murphy DL
    Am J Psychiatry; 1986 Nov; 143(11):1494-5. PubMed ID: 3777262
    [No Abstract]   [Full Text] [Related]  

  • 37. Advances in the pharmacotherapy of Alzheimer's disease.
    Soares JC; Gershon S
    Eur Arch Psychiatry Clin Neurosci; 1994; 244(5):261-71. PubMed ID: 7893772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent developments in the psychopharmacology of social phobia.
    Den Boer JA; van Vliet IM; Westenberg HG
    Eur Arch Psychiatry Clin Neurosci; 1995; 244(6):309-16. PubMed ID: 7772614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral effects of a synthetic corticotropin 4-9 analog in patients with depression and patients with Alzheimer's disease.
    Heuser I; Heuser-Link M; Gotthardt U; Grasser A; Holsboer F
    J Clin Psychopharmacol; 1993 Jun; 13(3):171-4. PubMed ID: 8394847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.